These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 26671119)
1. Does Parkinson's disease lead to alterations in the facial expression of pain? Priebe JA; Kunz M; Morcinek C; Rieckmann P; Lautenbacher S J Neurol Sci; 2015 Dec; 359(1-2):226-35. PubMed ID: 26671119 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiological assessment of nociception in patients with Parkinson's disease: A multi-methods approach. Priebe JA; Kunz M; Morcinek C; Rieckmann P; Lautenbacher S J Neurol Sci; 2016 Sep; 368():59-69. PubMed ID: 27538603 [TBL] [Abstract][Full Text] [Related]
3. Response to heat pain stimulation in idiopathic Parkinson's disease. Nandhagopal R; Troiano AR; Mak E; Schulzer M; Bushnell MC; Stoessl AJ Pain Med; 2010 Jun; 11(6):834-40. PubMed ID: 20624238 [TBL] [Abstract][Full Text] [Related]
4. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease. Dumer AI; Oster H; McCabe D; Rabin LA; Spielman JL; Ramig LO; Borod JC J Int Neuropsychol Soc; 2014 Mar; 20(3):302-12. PubMed ID: 24524211 [TBL] [Abstract][Full Text] [Related]
5. Voluntary control of facial musculature in Parkinson's disease. Marneweck M; Hammond G J Neurol Sci; 2014 Dec; 347(1-2):332-6. PubMed ID: 25467144 [TBL] [Abstract][Full Text] [Related]
6. Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? Ricciardi L; Bologna M; Morgante F; Ricciardi D; Morabito B; Volpe D; Martino D; Tessitore A; Pomponi M; Bentivoglio AR; Bernabei R; Fasano A J Neurol Sci; 2015 Nov; 358(1-2):125-30. PubMed ID: 26365284 [TBL] [Abstract][Full Text] [Related]
7. Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients. Grashorn W; Schunke O; Buhmann C; Forkmann K; Diedrich S; Wesemann K; Bingel U PLoS One; 2015; 10(8):e0135287. PubMed ID: 26270817 [TBL] [Abstract][Full Text] [Related]
8. Pain intensity on and off levodopa in patients with Parkinson's disease. Nebe A; Ebersbach G Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949 [TBL] [Abstract][Full Text] [Related]
14. Facilitated temporal summation of pain at spinal level in Parkinson's disease. Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260 [TBL] [Abstract][Full Text] [Related]
15. Negative impact of severity of pain on mood, social life and general activity in Parkinson's disease. Rana AQ; Qureshi ARM; Haris A; Danish MA; Furqan MS; Shaikh O; Sarfraz Z; Rana R Neurol Res; 2018 Dec; 40(12):1054-1059. PubMed ID: 30221591 [TBL] [Abstract][Full Text] [Related]
16. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease. Pellaprat J; Ory-Magne F; Canivet C; Simonetta-Moreau M; Lotterie JA; Radji F; Arbus C; Gerdelat A; Chaynes P; Brefel-Courbon C Parkinsonism Relat Disord; 2014 Jun; 20(6):662-4. PubMed ID: 24685343 [TBL] [Abstract][Full Text] [Related]
17. [Clinical variants of pain syndromes in patients with Parkinson's disease]. Makhnev SO; Levin OS Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):39-44. PubMed ID: 23994930 [TBL] [Abstract][Full Text] [Related]